Amide-Substituted Condensed Pyridine Derivatives as ACSS2 Inhibitors for Treating Cancer.
作者信息
Sabnis Ram W
机构信息
Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia30309, United States.
出版信息
ACS Med Chem Lett. 2021 Nov 8;12(12):1870-1871. doi: 10.1021/acsmedchemlett.1c00571. eCollection 2021 Dec 9.
Abstract
摘要
相似文献
1
Amide-Substituted Condensed Pyridine Derivatives as ACSS2 Inhibitors for Treating Cancer.作为用于治疗癌症的ACSS2抑制剂的酰胺取代稠合吡啶衍生物
ACS Med Chem Lett. 2021 Nov 8;12(12):1870-1871. doi: 10.1021/acsmedchemlett.1c00571. eCollection 2021 Dec 9.
2
Novel Substituted Tetrazoles as ACSS2 Inhibitors for Treating Cancer.新型取代四唑类化合物作为治疗癌症的ACSS2抑制剂
ACS Med Chem Lett. 2021 Nov 24;12(12):1894-1895. doi: 10.1021/acsmedchemlett.1c00621. eCollection 2021 Dec 9.
3
Highly selective inhibitors of thromboxane synthetase. 2. Pyridine derivatives.血栓素合成酶的高选择性抑制剂。2. 吡啶衍生物。
J Med Chem. 1981 Oct;24(10):1149-55. doi: 10.1021/jm00142a006.
4
Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism.乙酰辅酶A合成酶2作为肿瘤代谢中的治疗靶点
Cancers (Basel). 2022 Jun 12;14(12):2896. doi: 10.3390/cancers14122896.
5
Thrombin inhibitors. 2. Amide derivatives of N alpha-substituted L-arginine.凝血酶抑制剂。2. Nα-取代的L-精氨酸的酰胺衍生物。
J Med Chem. 1980 Aug;23(8):830-6. doi: 10.1021/jm00182a004.
6
Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway.乙酰辅酶 A 合成酶 2 通过 SIRT1/ChREBP 通路重排脂肪酸代谢促进小鼠糖尿病肾小管损伤。
Acta Pharmacol Sin. 2024 Feb;45(2):366-377. doi: 10.1038/s41401-023-01160-0. Epub 2023 Sep 28.
7
Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth.用过渡态模拟物靶向ACSS2可抑制三阴性乳腺癌的生长。
Cancer Res. 2021 Mar 1;81(5):1252-1264. doi: 10.1158/0008-5472.CAN-20-1847. Epub 2021 Jan 7.
8
Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells.乙酰辅酶A合成酶ACSS1和ACSS2是4-羟基他莫昔芬反应因子，可促进他莫昔芬处理的细胞和雌激素剥夺细胞的存活。
Transl Oncol. 2022 May;19:101386. doi: 10.1016/j.tranon.2022.101386. Epub 2022 Mar 6.
9
Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growth.发现新型可穿透脑屏障的人ACSS2抑制剂以阻断乳腺癌脑转移生长。
bioRxiv. 2023 Dec 23:2023.12.22.573073. doi: 10.1101/2023.12.22.573073.
10
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells.选择性且可穿透血脑屏障的ACSS2抑制剂靶向乳腺癌脑转移细胞。
Front Pharmacol. 2024 May 16;15:1394685. doi: 10.3389/fphar.2024.1394685. eCollection 2024.
引用本文的文献
1
A Computational Approach for Designing a Peptide-Based Acetyl-CoA Synthetase 2 Inhibitor: A New Horizon for Anticancer Development.一种基于肽的乙酰辅酶A合成酶2抑制剂设计的计算方法：抗癌药物研发的新视野
Cell Biochem Biophys. 2025 Apr 27. doi: 10.1007/s12013-025-01729-y.
2
Acetyl-CoA: An interplay between metabolism and epigenetics in cancer.乙酰辅酶A：癌症中代谢与表观遗传学之间的相互作用
Front Mol Med. 2022 Nov 16;2:1044585. doi: 10.3389/fmmed.2022.1044585. eCollection 2022.
3
ACSS2 enables melanoma cell survival and tumor metastasis by negatively regulating the Hippo pathway.ACSS2通过负向调节Hippo信号通路来促进黑色素瘤细胞存活和肿瘤转移。
Front Mol Biosci. 2024 Jun 3;11:1423795. doi: 10.3389/fmolb.2024.1423795. eCollection 2024.
4
Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.食管癌中异常脂质代谢重编程与免疫微环境的靶向策略：综述
J Oncol. 2022 Sep 5;2022:4257359. doi: 10.1155/2022/4257359. eCollection 2022.
5
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage.胶质母细胞瘤中的脂质代谢：从从头合成到储存
Biomedicines. 2022 Aug 11;10(8):1943. doi: 10.3390/biomedicines10081943.
6
Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development.乙酰辅酶A合成酶2（ACSS2）：一篇聚焦于代谢与肿瘤发展的综述
Discov Oncol. 2022 Jul 7;13(1):58. doi: 10.1007/s12672-022-00521-1.
7
Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism.乙酰辅酶A合成酶2作为肿瘤代谢中的治疗靶点
Cancers (Basel). 2022 Jun 12;14(12):2896. doi: 10.3390/cancers14122896.
本文引用的文献
1
Moonlighting functions of metabolic enzymes and metabolites in cancer.代谢酶和代谢物在癌症中的兼职功能。
Mol Cell. 2021 Sep 16;81(18):3760-3774. doi: 10.1016/j.molcel.2021.08.031.
2
Histone acylations and chromatin dynamics: concepts, challenges, and links to metabolism.组蛋白酰化和染色质动力学：概念、挑战以及与代谢的联系。
EMBO Rep. 2021 Jul 5;22(7):e52774. doi: 10.15252/embr.202152774. Epub 2021 Jun 23.
3
Therapeutic targeting of chromatin: status and opportunities.靶向染色质治疗：现状与机遇。
FEBS J. 2022 Mar;289(5):1276-1301. doi: 10.1111/febs.15966. Epub 2021 Jun 25.
4
Acetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan.衰老和寿命调控中的乙酰辅酶A代谢与组蛋白乙酰化
Antioxidants (Basel). 2021 Apr 8;10(4):572. doi: 10.3390/antiox10040572.
5
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance.《脂肪与愤怒：抗肿瘤治疗反应和耐药中的脂质代谢》
Trends Cancer. 2021 Mar;7(3):198-213. doi: 10.1016/j.trecan.2020.10.004. Epub 2020 Dec 16.
6
Compartmentalised acyl-CoA metabolism and roles in chromatin regulation.区室化酰基辅酶 A 代谢及其在染色质调控中的作用。
Mol Metab. 2020 Aug;38:100941. doi: 10.1016/j.molmet.2020.01.005. Epub 2020 Feb 14.
Zotero 插件